THC Therapeutics, Inc.
THCT
$0.0001
-$0.0002-66.67%
OTC PK
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.88% | -75.61% | -72.94% | -71.71% | -36.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.88% | -75.61% | -72.94% | -71.71% | -36.94% |
| Operating Income | 40.88% | 75.61% | 72.94% | 71.71% | 36.94% |
| Income Before Tax | -31,166.67% | 21.35% | 153.20% | 74.53% | 99.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31,166.67% | 21.35% | 153.20% | 74.53% | 99.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31,166.67% | 21.35% | 153.20% | 74.53% | 99.94% |
| EBIT | 40.88% | 75.61% | 72.94% | 71.71% | 36.94% |
| EBITDA | 40.90% | 75.63% | 72.89% | 71.59% | 36.43% |
| EPS Basic | -5,966.67% | 21.27% | 154.38% | 74.39% | 100.30% |
| Normalized Basic EPS | -5,600.00% | 21.01% | 154.39% | 74.29% | 100.32% |
| EPS Diluted | -5,966.67% | 21.27% | 154.38% | 74.39% | 100.30% |
| Normalized Diluted EPS | -5,600.00% | 21.01% | 154.39% | 74.29% | 100.32% |
| Average Basic Shares Outstanding | 4.66% | 0.58% | -1.72% | -1.20% | 4.26% |
| Average Diluted Shares Outstanding | 4.66% | 0.58% | -1.72% | -1.20% | 4.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |